| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |